Particle compositions with a pre-selected cell internalization mode
View Patent ↗A method of formulating a particle composition having a pre-selected cell internalization mode involves selecting a target cell having surface receptors and obtaining particles that have i) surface moieties, that have an affinity for or are capable of binding to the surface receptors of the cell and ii) a preselected shape, where a surface distribution of the surface moieties on the particles and the shape of the particles are effective for the pre-selected cell internalization mode.
1. A method of formulating a particle composition having a preselected cell internalization mode, comprising:
a) selecting a cell having surface receptors; and
b) fabricating ellipsoidal particles that have i) surface moieties that have an affinity for or are capable of binding to the receptors, and ii) an aspect ratio that is effective for the preselected cell internalization mode for the selected cell, wherein the pre-selected internalization mode is selected from a full endocytosis, a frustrated endocytosis and no endocytosis.
2. The method of claim 1 , wherein the cell is an endothelial cell.
3. The method of claim 2 , wherein the endothelial cell is an endothelial vasculature cell.
4. The method of claim 3 , wherein the receptors are angiogenesis vasculature receptors, coopted vasculature receptors or renormalized receptors.
5. The method of claim 1 , wherein the cell is a non-phagocyte cell.
6. The method of claim 1 , wherein the surface moieties are ligands that are capable of binding to the receptors.
7. The method of claim 1 , wherein the fabricating comprises fabricating by a top-down process.
8. The method of claim 1 , wherein the fabricating comprises disposing the moieties onto a surface of the particles.
9. The method of claim 1 , wherein the obtaining comprises selecting the particles from a particle population.
10. The method of claim 1 , wherein the particles comprise an active agent.
11. The method of claim 10 , wherein the active agent comprises an imaging agent or a therapeutic agent.
12. The method of claim 1 , wherein said particles are nanoparticles.
13. The method of claim 1 , further comprising determining the aspect ratio based on a surface density of the surface moieties and a surface density of the surface receptors.